IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v12y1992i4p239-249.html
   My bibliography  Save this article

Treatment of Chronic Nonvalvular Atrial Fibrillation in the Elderly

Author

Listed:
  • I. Gary Naglie
  • Allan S. Detsky

Abstract

The objective of the study was to determine the preferred treatment strategy for elderly patients with chronic nonvalvular atrial fibrillation (CNVAF). A Markov decision-analytic model was used to compare three treatment strategies for CNVAF: 1) warfarin; 2) aspirin; and 3) no treatment. Five-year quality-adjusted life years (QALYs) were calculated for male and female cohorts aged 70 and 75 years. In the baseline analysis (effectiveness of warfarin = 0.70, effectiveness of aspirin = 0.45, utility of warfarin = 0.99, and utility of aspirin = 0.999) the quality-adjusted survival rates for 70-year-old males were 4.03 QALYs on warfarin, 4.02 QALYs on aspirin, and 3.95 QALYs on no treatment. Results were similar for all age and sex cohorts. Sensitivity analyses revealed that the results were very sensitive to the effec tiveness of aspirin and the disutility of warfarin. The authors conclude that the optimal strategy for the treatment of CNVAF in elderly patients varies with the disutility assigned to warfarin therapy and the effectiveness value for aspirin therapy. Key words: chronic atrial fibrillation; elderly; anticoagulation; warfarin; aspirin; decision analysis; Markov analysis; quality of life. (Med Decis Making 1992;12:239-249)

Suggested Citation

  • I. Gary Naglie & Allan S. Detsky, 1992. "Treatment of Chronic Nonvalvular Atrial Fibrillation in the Elderly," Medical Decision Making, , vol. 12(4), pages 239-249, December.
    • Handle: RePEc:sae:medema:v:12:y:1992:i:4:p:239-249
    DOI: 10.1177/0272989X9201200401
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X9201200401
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X9201200401?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mark H. Eckman & Sushil K. Singh & John K. Erban & Grace Kao, 2002. "Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis," Medical Decision Making, , vol. 22(2), pages 108-124, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:12:y:1992:i:4:p:239-249. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.